These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 1491839

  • 1. Cognition and 99Tcm-HMPAO SPECT in Parkinson's disease.
    Liu RS, Lin KN, Wang SJ, Shan DE, Fuh JL, Yeh SH, Liu HC.
    Nucl Med Commun; 1992 Oct; 13(10):744-8. PubMed ID: 1491839
    [Abstract] [Full Text] [Related]

  • 2. Technetium-99m hexamethylpropylene amine oxime single photon emission tomography of the brain in early Parkinson's disease: correlation with dementia and lateralization.
    Wang SJ, Liu RS, Liu HC, Lin KN, Shan DE, Liao KK, Fuh JL, Lee LS.
    Eur J Nucl Med; 1993 Apr; 20(4):339-44. PubMed ID: 8491227
    [Abstract] [Full Text] [Related]

  • 3. Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.
    Derejko M, Sławek J, Wieczorek D, Brockhuis B, Dubaniewicz M, Lass P.
    Nucl Med Commun; 2006 Dec; 27(12):945-51. PubMed ID: 17088679
    [Abstract] [Full Text] [Related]

  • 4. Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson's disease--a rCBF scintigraphy study.
    Wallin A, Ekberg S, Lind K, Milos V, Granérus AK, Granerus G.
    Acta Neurol Scand; 2007 Dec; 116(6):347-54. PubMed ID: 17927803
    [Abstract] [Full Text] [Related]

  • 5. Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease.
    Defebvre LJ, Leduc V, Duhamel A, Lecouffe P, Pasquier F, Lamy-Lhullier C, Steinling M, Destée A.
    J Nucl Med; 1999 Jun; 40(6):956-62. PubMed ID: 10452310
    [Abstract] [Full Text] [Related]

  • 6. 99Tcm-HMPAO SPECT in suspected dementia.
    Launes J, Sulkava R, Erkinjuntti T, Nikkinen P, Lindroth L, Liewendahl K, Iivanainen M.
    Nucl Med Commun; 1991 Sep; 12(9):757-65. PubMed ID: 1945187
    [Abstract] [Full Text] [Related]

  • 7. HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness.
    Markus HS, Costa DC, Lees AJ.
    J Neurol Neurosurg Psychiatry; 1994 Feb; 57(2):180-5. PubMed ID: 8126501
    [Abstract] [Full Text] [Related]

  • 8. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls.
    Wyper D, Teasdale E, Patterson J, Montaldi D, Brown D, Hunter R, Graham D, McCulloch J.
    Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246
    [Abstract] [Full Text] [Related]

  • 9. (99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: a correlation with neuropsychological tests.
    Chang CC, Liu JS, Chang YY, Chang WN, Chen SS, Lee CH.
    Eur J Neurol; 2008 Jan; 15(1):61-5. PubMed ID: 18042240
    [Abstract] [Full Text] [Related]

  • 10. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment.
    Osimani A, Ichise M, Chung DG, Pogue JM, Freedman M.
    Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.
    Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A.
    J Nucl Med; 1992 Feb; 33(2):181-5. PubMed ID: 1732438
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regional cerebral blood flow of Alzheimer's disease-like pattern in young patients with Down's syndrome detected by 99Tcm-HMPAO brain SPECT.
    Kao CH, Wang PY, Wang SJ, Chou KT, Hsu CY, Lin WY, Liao SQ, Yeh SH.
    Nucl Med Commun; 1993 Jan; 14(1):47-51. PubMed ID: 8423935
    [Abstract] [Full Text] [Related]

  • 15. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
    Pickut BA, Saerens J, Mariën P, Borggreve F, Goeman J, Vandevivere J, Vervaet A, Dierckx R, de Deyn PP.
    J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
    [Abstract] [Full Text] [Related]

  • 16. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease.
    Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G.
    Neurol Sci; 2001 Feb; 22(1):45-6. PubMed ID: 11487194
    [Abstract] [Full Text] [Related]

  • 17. Early diagnosis of Alzheimer's disease and Parkinson's disease associated with dementia using cerebral perfusion SPECT.
    Song IU, Chung YA, Chung SW, Jeong J.
    Dement Geriatr Cogn Disord; 2014 Feb; 37(5-6):276-85. PubMed ID: 24356537
    [Abstract] [Full Text] [Related]

  • 18. CBF tomograms with [99mTc-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease--initial results.
    Costa DC, Ell PJ, Burns A, Philpot M, Levy R.
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S109-15. PubMed ID: 3263977
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease.
    Hashikawa K, Matsumoto M, Moriwaki H, Oku N, Okazaki Y, Seike Y, Uehara T, Tanabe H, Ohie Y, Kamada T.
    J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.